NDC 72426-818

Nexlizet

Bempedoic Acid And Ezetimibe

Nexlizet is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Esperion Therapeutics, Inc.. The primary component is Bempedoic Acid; Ezetimibe.

Product ID72426-818_5dd83231-830c-482c-a341-d88c77c50c74
NDC72426-818
Product TypeHuman Prescription Drug
Proprietary NameNexlizet
Generic NameBempedoic Acid And Ezetimibe
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2020-03-09
Marketing CategoryNDA / NDA
Application NumberNDA211617
Labeler NameEsperion Therapeutics, Inc.
Substance NameBEMPEDOIC ACID; EZETIMIBE
Active Ingredient Strength180 mg/1; mg/1
Pharm ClassesDecreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 72426-818-03

30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72426-818-03)
Marketing Start Date2020-03-09
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72426-818-99 [72426081899]

Nexlizet TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA211617
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-03-09

NDC 72426-818-03 [72426081803]

Nexlizet TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA211617
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-03-09

NDC 72426-818-09 [72426081809]

Nexlizet TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA211617
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-03-09

Drug Details

Active Ingredients

IngredientStrength
BEMPEDOIC ACID180 mg/1

OpenFDA Data

SPL SET ID:3fa2108c-0300-47b8-9d34-f762af7c93c6
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 2283236
  • 2283230
  • UPC Code
  • 0372426818034
  • Pharmacological Class

    • Decreased Cholesterol Absorption [PE]
    • Dietary Cholesterol Absorption Inhibitor [EPC]

    Trademark Results [Nexlizet]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    NEXLIZET
    NEXLIZET
    88145092 not registered Live/Pending
    Esperion Therapeutics, Inc.
    2018-10-05

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.